首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1570571

採血市場、機會、成長動力、產業趨勢分析與預測，2024-2032

Blood Collection Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年08月02日 | 出版商:

Global Market Insights Inc. | 英文 139 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023 年全球血液採集市場價值約為109 億美元，預計2024 年至2032 年複合年成長率為6.9%。血液採集。這個市場是由心血管疾病、糖尿病、呼吸系統疾病和癌症等慢性疾病盛行率上升所推動的。技術進步、外科手術的增加以及老年人口的增加進一步推動了市場的成長。自動採血系統可減少人為錯誤並提高患者的舒適度。這些系統，包括自動靜脈穿刺設備，使用機器人技術和先進的成像技術來實現精確和一致的抽血。

整個採血產業根據車輛、產品類型、毛細管、方法、應用、最終用途和地區進行分類。

市場依產品類型分為靜脈和微血管。靜脈部分包括針頭和注射器、採血管、血袋和其他產品。毛細血管部分包括採血針、微容器管、微血細胞比容管、加溫裝置和其他產品。到 2032 年，靜脈部分預計將達到 127 億美元。

靜脈血液採集可產生更大的體積，這對於綜合測試和多重分析至關重要。靜脈樣本支持廣泛的診斷測試，包括生物化學、血液學、血清學和分子診斷。它們可以被分離成血漿或血清以進行專門測試。靜脈樣本更加一致和可靠，對於準確診斷和長期研究至關重要。與毛細管樣本相比，靜脈樣本面臨的溶血和污染等問題較少。

市場也依方法分為手動和自動採血。 2023 年，手排部分的銷售額為 71 億美元。注射器、針頭和刺血針等手動工具便於攜帶，非常適合偏遠地區、家訪或緊急情況。手動方法具有成本效益，需要最少的設備，使其適用於資源有限的環境。

到 2032 年，美國血液採集市場預計將達到 73 億美元。心血管疾病、糖尿病、呼吸系統疾病和癌症等慢性疾病盛行率的上升推動了市場的成長。 CDC 報告 2020 年美國新增癌症病例 1,603,844 例，死亡人數 602,347 人

產業生態系統分析
產業影響力
- 成長動力
  - 慢性病和傳染病的發生率上升
  - 血液採集技術的進步
  - 外科手術數量不斷增加
  - 老年人口不斷增加
- 產業陷阱與挑戰
  - 採血設備成本高
  - 與輸血相關的風險
成長潛力分析
監管環境
技術景觀
- 核心技術
- 鄰近技術
2023 年定價分析
- 按地區
- 按關鍵人物
未來市場趨勢
管道分析
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
公司矩陣分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按產品類型，2021 - 2032

主要趨勢
靜脈
- 針頭和注射器
  - 雙頭針
  - 有翼採血套裝
  - 標準皮下注射針頭
  - 其他採血針
- 採血管
  - 血清分離
  - 乙二胺四乙酸
  - 肝素
  - 血漿分離
- 血袋
- 其他靜脈產品
毛細管
- 柳葉刀
- 微型容器管
- 微量血球容積比管
- 加溫裝置
- 其他毛細管產品

第 6 章：市場估計與預測：依方法，2021 - 2032

主要趨勢
手動採血
自動採血

第 7 章：市場估計與預測：按應用分類，2021 - 2032

主要趨勢
診斷
治療
研究

第 8 章：市場估計與預測：按最終用途，2021 - 2032 年

主要趨勢
醫院和診所
診斷中心
血庫
學術及研究機構

第 9 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 10 章：公司簡介

Abbott Laboratories
Becton, Dickinson and Company
Cardinal Health, Inc.
F. Hoffmann-La Roche Ltd.
FL MEDICAL s.r.l.
Fresenius SE and Co. KGaA
Haemonetics Corporation
Greiner AG
McKESSON CORPORATION
Medtronic plc
Nipro Corporation
QIAGEN N.V.
Sarstedt AG and Co. KG
Siemens Healthineers AG
Terumo Corporation
Thermo Fisher Scientific Inc.

簡介目錄

Product Code: 10597

The Global Blood Collection Market was valued at approximately USD 10.9 billion in 2023 and is projected to grow at a CAGR of 6.9% from 2024 to 2032. Blood collection is crucial in healthcare for diagnosis, treatment, and research, involving venipuncture, fingerstick, or arterial draws. The market is driven by the rising prevalence of chronic diseases like cardiovascular ailments, diabetes, respiratory issues, and cancer. Technological advancements, an increase in surgical procedures, and a growing geriatric population further fuel market growth. Automated blood collection systems reduce human error and enhance patient comfort. These systems, including automated venipuncture devices, use robotics and advanced imaging for precise and consistent blood draws.

The overall blood collection industry is classified based on the vehicle, product type, capillary, method, application, end-use and region.

The market is segmented by product type into venous and capillary. The venous segment includes needles and syringes, blood collection tubes, blood bags, and other products. The capillary segment includes lancets, micro-container tubes, micro-hematocrit tubes, warming devices, and other products. The venous segment is projected to reach USD 12.7 billion by 2032.

Venous blood collection yields larger volumes, essential for comprehensive tests and multiple analyses. Venous samples support a wide range of diagnostic tests, including biochemistry, hematology, serology, and molecular diagnostics. They can be fractionated into plasma or serum for specialized tests. Venous samples are more consistent and reliable, crucial for accurate diagnostics and long-term studies. Venous samples face fewer issues like hemolysis and contamination compared to capillary samples.

The market is also segmented by method into manual and automated blood collection. The manual segment accounted for USD 7.1 billion in 2023. Manual techniques like venipuncture and fingerstick are easily performed with basic training, allowing quick responses to diverse patient needs. Manual tools, such as syringes, needles, and lancets, are portable and ideal for remote areas, home visits, or emergencies. Manual methods are cost-effective, requiring minimal equipment, making them viable for resource-limited settings.

The U.S. blood collection market is projected to reach USD 7.3 billion by 2032. The U.S. leads in healthcare technology and innovation, benefiting from advancements in blood collection technologies like automated venipuncture systems and microfluidic devices. The rising prevalence of chronic diseases, including cardiovascular ailments, diabetes, respiratory issues, and cancer, drives market growth. In 2020, the CDC reported 1,603,844 new cancer cases and 602,347 fatalities in the U.S.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising incidence of chronic and infectious diseases
  - 3.2.1.2 Advancements in blood collection technologies
  - 3.2.1.3 Increasing number of surgical procedures
  - 3.2.1.4 Rising geriatric population
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High cost of blood collection equipment
  - 3.2.2.2 Risks associated with blood transfusions
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
- 3.5.1 Core technologies
- 3.5.2 Adjacent technologies
3.6 Pricing analysis, 2023
- 3.6.1 By region
- 3.6.2 By key player
3.7 Future market trends
3.8 Pipeline analysis
3.9 Porter's analysis
3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Venous
- 5.2.1 Needles and syringes
  - 5.2.1.1 Double-ended needles
  - 5.2.1.2 Winged blood collection sets
  - 5.2.1.3 Standard hypodermic needles
  - 5.2.1.4 Other blood collection needles
- 5.2.2 Blood collection tubes
  - 5.2.2.1 Serum-separating
  - 5.2.2.2 EDTA
  - 5.2.2.3 Heparin
  - 5.2.2.4 Plasma-separating
- 5.2.3 Blood bags
- 5.2.4 Other venous products
5.3 Capillary
- 5.3.1 Lancets
- 5.3.2 Micro-container tubes
- 5.3.3 Micro-hematocrit tubes
- 5.3.4 Warming devices
- 5.3.5 Other capillary products

Chapter 6 Market Estimates and Forecast, By Method, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Manual blood collection
6.3 Automated blood collection

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Diagnostics
7.3 Treatment
7.4 Research

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Hospitals and clinics
8.3 Diagnostic centers
8.4 Blood banks
8.5 Academic and research institutes

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa